Rtx Income Statement Quarterly
RTX
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2024) III. Quarter |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
Total Revenue |
20,089.00 |
19,721.00 |
19,305.00 |
19,927.00 |
13,464.00 |
Cost of Goods and Services Sold |
12,336.00 |
12,625.00 |
12,216.00 |
12,347.00 |
9,289.00 |
Gross
Profit |
7,753.00 |
7,096.00 |
7,089.00 |
7,580.00 |
4,175.00 |
Selling, Administration, Marketing |
1,389.00 |
1,449.00 |
1,394.00 |
1,375.00 |
1,401.00 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research and Development Expense |
751.00 |
706.00 |
669.00 |
757.00 |
712.00 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
3,959.00 |
4,786.00 |
3,542.00 |
4,490.00 |
3,458.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component |
-374.00 |
-374.00 |
-386.00 |
-889.00 |
- |
Total operating costs including COS |
18,061.00 |
19,192.00 |
17,435.00 |
18,080.00 |
14,860.00 |
Operating income/-loss
|
2,028.00 |
529.00 |
1,870.00 |
1,847.00 |
-1,396.00 |
Other Deductions / - Income |
Interest expense |
496.00 |
475.00 |
405.00 |
488.00 |
369.00 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
496.00 |
475.00 |
405.00 |
488.00 |
369.00 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-374.00 |
-374.00 |
-386.00 |
-446.00 |
-443.00 |
Total costs & expenses |
18,183.00 |
19,293.00 |
17,454.00 |
18,122.00 |
14,786.00 |
Income /-loss before income taxes |
1,906.00 |
428.00 |
1,851.00 |
1,805.00 |
-1,322.00 |
Income taxes expenses/-benefit |
371.00 |
253.00 |
108.00 |
332.00 |
-389.00 |
Income after income taxes |
1,535.00 |
175.00 |
1,743.00 |
1,473.00 |
-933.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
1,535.00 |
175.00 |
1,743.00 |
1,473.00 |
-933.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
1,535.00 |
175.00 |
1,743.00 |
1,473.00 |
-933.00 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
63.00 |
64.00 |
34.00 |
47.00 |
51.00 |
Income/-loss to shareholder |
1,472.00 |
111.00 |
1,709.00 |
1,426.00 |
-984.00 |
EBIT |
2,402.00 |
903.00 |
2,256.00 |
2,293.00 |
-953.00 |
EBITD |
3,496.00 |
1,975.00 |
3,315.00 |
3,352.00 |
121.00 |
EBITDA |
3,496.00 |
1,975.00 |
3,315.00 |
3,352.00 |
121.00 |
Per
Share (GAAP Quarterly, in $) |
(Sep 30 2024) III. Quarter |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
Basic EPS (excl. extra
items) |
1.10 |
0.08 |
1.29 |
1.06 |
-0.68 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
1.10 |
0.08 |
1.29 |
1.06 |
-0.68 |
Basic shares outstanding (Mill.
of Units) |
1,338.18 |
1,387.50 |
1,324.81 |
1,343.60 |
1,447.06 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
1.09 |
0.08 |
1.28 |
1.06 |
-0.68 |
Diluted average shares (Mill.
of Units) |
1,350.46 |
1,387.50 |
1,335.16 |
1,432.74 |
1,447.06 |
Dividend per share |
0.609 |
0.593 |
0.576 |
0.535 |
0.579 |
|
|